analyz
effect
inhibitor
block
replic
negativestrand
rna
virus
cell
infect
prototyp
neg
strand
viru
vesicular
stomat
viru
vsv
inhibit
activ
reduc
viral
replic
cell
infect
high
low
multipl
infect
inhibit
observ
use
two
inhibitor
geldanamycin
radicicol
silenc
express
use
sirna
also
reduc
viral
replic
inhibit
chang
halflif
newli
synthes
l
protein
larg
subunit
vsv
polymeras
hour
less
minut
without
affect
stabil
vsv
protein
inhibit
viral
replic
destabil
viral
l
protein
seen
either
geldanamycin
radicicol
ad
cell
infect
paramyxovirus
cell
infect
la
cross
bunyaviru
base
result
propos
host
factor
import
replic
mani
neg
strand
virus
signific
scientif
public
health
interest
virus
util
neg
strand
rna
genom
mani
virus
import
pathogen
includ
signific
recur
infecti
diseas
problem
influenza
respiratori
syncyti
viru
well
alarm
emerg
infecti
diseas
lassa
marburg
hanta
rift
valley
fever
virus
encod
rna
depend
rna
polymeras
rdrp
rdrp
requir
viral
transcript
replic
viral
genom
whelan
barr
wertz
addit
rna
polymer
rdrp
also
involv
end
modif
recogn
cisact
sequenc
govern
transcript
replic
function
rdrp
differ
virus
appear
util
divers
strategi
accomplish
task
repeat
theme
rdrp
requir
either
cooper
viral
protein
gupta
shaji
banerje
whelan
barr
wertz
host
protein
da
et
al
shen
master
strauss
strauss
properli
accomplish
replic
andor
transcript
understand
virusviru
virushost
interact
govern
neg
strand
viru
replic
import
develop
way
combat
import
infecti
agent
block
abil
replic
heat
shock
protein
cellular
chaperon
focu
intens
research
mani
year
review
see
terasawa
minami
minami
young
moarefi
hartl
knockout
model
shown
essenti
viabil
yeast
drosophila
lang
et
al
panaret
et
al
rutherford
lindquist
display
atpdepend
fold
capac
panaret
et
al
notabl
among
chaperon
protein
unlik
promiscu
cousin
chaperon
agash
hartl
appear
specif
set
client
protein
vivo
pratt
toft
client
protein
includ
steroid
receptor
number
transcript
factor
sever
protein
kinas
terasawa
minami
minami
form
complex
cochaperon
ie
act
fold
client
protein
sever
known
oncogen
client
protein
pratt
toft
spark
interest
use
inhibitor
block
fold
oncogen
protein
effort
drive
cancer
cell
apoptosi
whitesel
lindquist
involv
viral
replic
report
sever
differ
virus
howev
report
suggest
differ
role
varieti
viru
host
system
vaccinia
viru
infect
inhibit
block
viral
replic
hung
chung
chang
mechan
inhibit
well
establish
local
restrict
cytoplasm
follow
vv
infect
interact
viral
core
protein
presum
client
protein
hung
chung
chang
activ
also
report
import
proper
cleavag
newli
synthes
hepat
c
protein
waxman
et
al
requir
activ
hepat
b
revers
transcriptas
hu
seeger
hu
toft
seeger
recent
sever
report
implic
role
control
viral
polymeras
function
minireplicon
system
bind
subunit
influenza
viru
rna
polymeras
stimul
viral
polymeras
activ
momos
et
al
herp
viru
infect
block
activ
significantli
inhibit
viral
replic
burch
weller
li
et
al
possibl
due
improp
local
viral
polymeras
drugtreat
cell
cytoplasm
rather
nuclear
similarli
shown
activ
import
proper
stabil
local
rna
polymeras
protein
insect
viru
flock
hous
viru
kampmuel
miller
still
great
deal
discov
role
viru
replic
whether
like
play
role
life
cycl
specif
virus
whether
involv
life
cycl
entir
class
virus
attempt
address
question
studi
effect
inhibitor
replic
sever
differ
neg
strand
rna
virus
rhabdoviru
paramyxoviru
bunyaviru
famili
found
replic
virus
famili
impair
ansamycin
inhibitor
geldanamycin
second
inhibitor
radicicol
sirna
knockdown
protein
level
inhibit
replic
appar
earli
stage
viru
life
cycl
result
select
destabil
l
protein
viru
polymeras
base
data
literatur
propos
virus
multipl
famili
class
evolv
requir
use
proper
fold
polymeras
suggest
inhibit
activ
could
act
broadrang
antivir
agent
determin
whether
inhibit
effect
replic
prototyp
neg
strand
viru
vesicular
stomat
viru
vsv
determin
viral
growth
cell
treat
increas
concentr
geldanamycin
atpcompetitor
act
specif
inhibitor
activ
roe
et
al
util
chemic
synthes
geldanamycin
provid
dtp
servic
nci
experi
recent
report
shown
geldanamycin
purifi
hygroscopicu
contain
contamin
activ
inhibit
intracellular
traffick
nci
synthes
compound
barzilay
et
al
bhk
cell
infect
vsv
moi
treat
increas
concentr
drug
viru
yield
determin
plaqu
assay
shown
figur
geldanamycin
potent
inhibitor
vsv
growth
reduc
viru
replic
order
magnitud
order
magnitud
understand
effect
geldanamycin
viru
replic
carri
singl
multipl
cycl
growth
experi
absenc
presenc
geldanamycin
concentr
previous
shown
minim
cellular
toxic
kampmuel
miller
shown
figur
geldanamycin
signific
effect
slow
viru
growth
singl
cycl
growth
experi
cell
infect
vsv
treat
geldanamycin
show
notic
delay
viru
growth
produc
lower
viru
titer
hpi
compar
cell
infect
vsv
treat
geldanamycin
viru
titer
compar
drug
treat
untreat
condit
inhibit
vsv
replic
geldanamycin
seen
hela
cell
well
bhk
cell
data
shown
indic
effect
celltyp
specif
inhibit
viral
replic
geldanamycin
dramat
multicycl
growth
experi
geldanamycin
addit
delay
appear
progeni
virus
hour
compar
infect
cell
treat
geldanamycin
inhibit
growth
two
order
magnitud
figur
also
determin
effect
radicicol
inhibitor
structur
distinct
geldanamycin
high
moi
vsv
infect
radicicol
also
inhibit
vsv
replic
decreas
viru
titer
order
magnitud
order
magnitud
support
hypothesi
mechan
replic
inhibit
inhibit
function
figur
test
conclus
util
differ
method
determin
effect
decreas
level
rna
silenc
figur
show
repres
western
blot
hela
cell
either
mock
transfect
transfect
sirna
target
gapdh
transfect
sirna
target
hour
posttransfect
cell
transfect
gapdh
sirna
show
inhibit
gapdh
express
lane
cell
transfect
sirna
target
alpha
beta
form
show
drop
level
time
posttransfect
lane
cell
cultur
transfect
either
gapdh
sirna
fewer
cell
contol
posttransfect
suggest
cell
prolifer
slow
supplement
figur
howev
signific
differ
cell
viabil
gross
morpholog
chang
cell
transfect
sirna
determin
effect
lower
level
protein
level
vsv
infect
cell
infect
vsv
low
moi
analysi
viral
growth
plaqu
assay
figur
show
cell
silenc
show
decreas
viru
titer
compar
mocktransfect
control
neglig
effect
gapdh
silenc
viru
titer
result
support
conclus
import
host
factor
replic
vsv
timecours
shown
figur
indic
geldanamycin
inhibit
vsv
earli
time
vsv
life
cycl
inhibitori
action
diminish
later
time
postinfect
singlecycl
growth
experi
drug
ad
coincid
infect
strong
effect
viral
replic
drug
ad
four
hour
postinfect
almost
effect
data
shown
suggest
antivir
activ
geldanamycin
due
effect
earli
ratelimit
step
viral
replic
determin
addit
geldanamycin
affect
viral
gene
express
cell
infect
vsv
drug
ad
see
figur
time
line
cell
label
methionin
hour
lysat
analyz
sdspage
phosphorimag
cell
treat
drug
high
level
vsv
gene
express
evid
appear
four
major
band
repres
l
g
np
comigr
protein
figur
lane
also
appar
inhibit
host
protein
synthesi
normal
seen
follow
product
vsv
infect
addit
geldanamycin
coincid
viru
infect
block
viral
gene
express
vsv
host
protein
synthesi
still
detect
lane
cell
treat
drug
show
decreas
viral
gene
express
cell
treat
drug
show
strong
viral
gene
express
demonstr
geldanamycin
inhibit
viral
gene
express
requir
addit
soon
initi
infect
shown
figur
addit
drug
result
one
chang
nontreat
cell
viral
l
protein
catalyt
activ
compon
rdrp
accumul
much
lower
level
drugtreat
cell
investig
whether
lower
level
l
protein
due
increas
incorpor
l
bud
virion
determin
extent
newli
synthes
l
incorpor
bud
virion
infect
cell
treat
geldanamycin
protein
label
methionin
hour
fate
newli
synthes
protein
determin
analysi
virion
bud
supernat
label
protein
cell
hour
chase
unlabel
methionin
protein
produc
vsv
unaffect
addit
geldanamycin
level
l
protein
cell
lysat
decreas
increas
geldanamycin
concentr
figur
drug
addit
concentr
low
decreas
amount
l
lysat
consist
disappear
l
protein
link
effect
drug
viral
replic
figur
bud
virion
purifi
supernat
cell
concentr
geldanamycin
effect
amount
radiolabel
g
n
p
protein
incorpor
figur
demonstr
block
affect
assembl
function
viru
case
l
protein
less
radiolabel
l
protein
incorpor
virion
geldanamycin
concentr
increas
result
show
geldanamycin
treatment
result
preferenti
movement
newli
synthes
l
protein
virion
newli
synthes
l
found
virion
cell
treat
lower
concentr
drug
indic
newli
synthes
l
protein
remain
cell
long
enough
incorpor
virion
determin
synthesi
stabil
l
chang
follow
inhibit
perform
pulsechas
analysi
presenc
absenc
geldanamycin
radiolabel
cell
chase
minut
lysat
cell
analyz
phosphorimag
figur
result
imag
show
geldanamycintr
untreat
cell
infect
viru
signific
amount
methionin
incorpor
viral
l
protein
newli
synthes
l
protein
stabl
untreat
cell
disappear
rapidli
cell
treat
drug
almost
complet
absent
minut
chase
quantit
data
figur
multipl
experi
show
halflif
l
protein
greater
minut
absenc
drug
reduc
less
minut
presenc
drug
seen
viral
protein
analysi
decay
viral
protein
figur
viral
protein
figur
show
littl
evid
degrad
presenc
absenc
drug
treatment
investig
possibl
mechan
observ
destabil
l
protein
follow
inhibit
determin
whether
l
protein
degrad
via
proteasom
possibl
particularli
plausibl
substrat
estrogen
receptor
shown
shunt
proteasom
pathway
follow
inhibit
bagatel
et
al
fan
park
nephew
test
whether
proteasom
involv
degrad
newli
synthes
l
protein
repeat
experi
shown
figur
ad
proteasom
inhibitor
proteasom
inhibitor
ii
calbiochem
infect
cell
treat
geldanamycin
minut
chase
similar
level
incorpor
methionin
l
protein
untreat
geldanamycin
treat
geldanamycin
proteasom
inhibitor
treat
condit
figur
minut
chase
signific
decreas
amount
l
protein
geldanamycin
treat
cell
similar
seen
previou
experi
much
smaller
decreas
cell
treat
geldanamycin
proteasom
inhibitor
show
proteasom
inhibit
decreas
degrad
l
protein
addit
proteosom
inhibitor
alon
significantli
alter
stabil
l
protein
figur
quantit
multipl
experi
figur
show
addit
proteasom
inhibitor
increas
l
protein
halflif
presenc
geldanamycin
less
minut
close
l
control
cell
reciev
geldanamycin
dot
line
figur
argu
primari
caus
disappear
newli
synthes
l
polymeras
follow
inhibit
target
newli
synthes
polymeras
proteasom
base
find
inhibitor
decreas
replic
destabil
l
polymeras
protein
prototyp
neg
strand
viru
vsv
interest
whether
behavior
uniqu
vsv
whether
gener
phenomenon
test
hypothesi
activ
requir
replic
polymeras
stabil
across
neg
strand
viru
famili
initi
test
paramyxovirus
simian
viru
determin
effect
inhibit
viral
replic
geldanamycin
ad
cell
infect
low
multipl
gfpexpress
shown
figur
geldanamycin
inhibit
growth
virus
reduc
viru
yield
log
log
geldanamycin
radicicol
block
paramyxoviru
spread
low
moi
infect
cell
infect
moi
infect
express
gfp
figur
left
panel
consist
effect
inhibitor
viru
product
cell
infect
treat
geldanamycin
show
dramat
lower
viral
spread
cell
show
gfp
express
middl
panel
similar
limit
spread
seen
cell
treat
radicicol
cell
show
intens
gfp
signal
seen
mockinfect
cell
right
panel
use
sirna
decreas
level
protein
cell
also
signific
effect
paramyxoviru
replic
shown
figur
viru
titer
hela
cell
either
mock
transfect
transfect
sirna
target
gapdh
transfect
sirna
target
silenc
gapdh
minim
decreas
replic
silenc
reduc
replic
significantli
progeni
virus
detect
cell
infect
log
order
differ
compar
control
gapdhsilenc
cell
viru
replic
observ
lower
level
seen
control
silenc
express
silenc
gapdh
express
inhibit
spread
gfp
figur
cell
inhibit
paramyxoviru
growth
accompani
chang
stabil
viral
polymeras
figur
show
result
pulsechas
hour
chase
follow
immunoprecipit
indic
protein
experi
use
follow
stabil
individu
viral
protein
cell
infect
treat
geldanamycin
l
n
p
protein
show
stabl
profil
polymeras
protein
l
show
halflif
excess
hour
geldanamycintr
cell
infect
n
p
protein
remain
stabl
halflif
l
protein
drop
less
half
hour
follow
treatment
geldanamycin
similar
polymeras
destabil
observ
case
vsv
polymeras
addit
show
antivir
activ
geldanamycin
radicicol
show
antivir
activ
data
shown
analysi
viral
polymeras
virus
figur
directli
follow
puls
label
p
minut
one
hour
chase
c
show
polymeras
protein
stabl
absenc
geldanamycin
display
mark
decreas
halflif
l
polymeras
protein
follow
geldanamycin
addit
amount
label
l
protein
follow
minut
puls
reduc
presenc
geldanamycin
suggest
turnov
occur
puls
period
stabil
l
protein
appear
significantli
decreas
presenc
geldanamycin
suggest
rapid
turnov
l
protein
viru
follow
treatment
effect
destabil
viral
l
protein
attribut
inhibit
treatment
cell
infect
radicicol
also
caus
rapid
degrad
newli
synthes
viral
polymeras
figur
also
test
impact
inhibit
replic
bunyavirus
famili
negativestrand
virus
contain
segment
rna
genom
case
pediatr
enceph
viru
la
cross
viru
strain
chandler
et
al
kind
gift
bj
beati
viru
growth
also
inhibit
geldanamycin
figur
radicicol
data
shown
concentr
low
cell
treat
drug
la
cross
viru
infect
result
develop
notic
cytopath
effect
figur
middl
panel
infect
la
cross
presenc
geldanamycin
prevent
develop
cytopath
effect
figur
consist
observ
inhibit
viru
replic
similar
vsv
paramyxoviru
famili
member
inhibit
appear
destabil
viral
polymeras
pulsechas
analysi
la
cross
viru
protein
infect
cell
minut
puls
follow
hour
chase
show
la
cross
l
protein
normal
stabl
distinct
decreas
l
protein
stabil
follow
addit
geldanamycin
figur
top
panel
la
cross
viru
protein
glycoprotein
remain
stabl
bottom
panel
experi
describ
demonstr
geneknockdown
cellperm
inhibitor
approach
activ
import
rapid
growth
neg
strand
rna
virus
mechanist
geldanamycin
inhibitor
appear
block
viru
replic
dramat
decreas
stabil
l
subunit
viral
rna
depend
rna
polymeras
mode
action
would
explain
effect
inhibit
earli
stage
viral
infect
level
rna
synthesi
genom
replic
would
affect
decreas
level
viral
polymeras
ad
geldanamycin
progress
later
time
postinfect
progress
less
effect
viral
gene
express
indic
accumul
l
protein
prior
drug
addit
compens
rapid
turnov
newli
synthes
l
protein
studi
show
virus
rhabdoviru
paramyxoviru
bunyaviru
famili
requir
activ
achiev
normal
level
stabl
viral
polymeras
research
shown
positivestrand
rna
viru
fhv
polymeras
kampmuel
miller
influenza
viru
polymeras
momos
et
al
requir
activ
proper
function
togeth
data
laboratori
kampmuel
miller
momos
et
al
suggest
host
factor
central
import
viral
replic
mani
rna
virus
rna
polymeras
differ
virus
share
high
degre
sequenc
homolog
depend
point
converg
evolut
knowledg
first
propos
activ
conserv
requir
achiev
stabl
viru
polymeras
wide
spectrum
rna
virus
vsv
l
protein
larg
size
kda
exist
sever
differ
catalyt
activ
within
protein
feller
et
al
grdzelishvili
et
al
li
fontainerodriguez
whelan
li
wang
whelan
impli
number
independ
fold
domain
also
like
true
viral
polymeras
affect
inhibit
virus
use
studi
rel
larg
polymeras
protein
like
independ
function
domain
involv
fold
polymeras
yet
determin
protein
fold
activ
requir
bind
action
addit
cochaperon
fold
viral
polymeras
like
coordin
effort
sever
cellular
protein
first
identifi
despit
attract
hypothes
directli
involv
fold
viral
polymeras
possibl
exist
inhibit
might
destabil
rna
viru
polymeras
virus
rhabdoviru
paramyxoviru
famili
l
polymeras
requir
bind
viral
phospho
p
protein
activ
horikami
et
al
may
facilit
lp
interact
promot
stabil
l
could
also
act
promot
stabl
format
l
protein
multim
smallwood
cevik
moyer
thu
inhibit
could
lead
disrupt
interact
result
unstabl
polymeras
quickli
degrad
addit
may
remot
involv
impact
l
stabil
fold
activ
cellular
compon
requir
polymeras
stabil
experi
requir
determin
interact
rna
viru
polymeras
well
cellular
factor
import
replic
multipl
virus
open
interest
possibl
develop
new
antivir
therapi
compound
display
antivir
activ
major
encephalitiscaus
hemorrhag
fever
caus
neg
strand
rna
virus
de
clercq
domachowsk
rosenberg
find
suggest
inhibit
activ
investig
mechan
limit
replic
spread
virus
vivo
advantag
approach
lack
activ
appear
hamper
viral
rdrp
function
rdrp
repres
rate
limit
enzym
step
viru
replic
perform
mani
uniqu
essenti
replic
function
synthes
rel
low
level
infect
cell
addit
effect
compound
wide
varieti
virus
inhibitor
may
broad
spectrum
antivir
capabl
inhibit
replic
sever
differ
infecti
agent
alreadi
signific
effort
devot
develop
inhibitor
one
compound
geldanamycin
deriv
complet
phase
current
phase
clinic
trial
anticanc
therapi
goetz
et
al
whitesel
lindquist
result
phase
trial
show
toler
dose
drug
led
decreas
level
client
protein
banerji
et
al
grem
et
al
thu
compound
alreadi
pass
mani
hurdl
confront
success
drug
develop
inhibitor
develop
whitesel
lindquist
like
clinic
viabl
regardless
util
cancer
treatment
propos
experiment
undertaken
determin
wither
compound
use
role
antivir
agent
inhibitor
may
also
work
synergist
antivir
ribavirin
drug
also
suggest
target
function
viral
polymeras
graci
cameron
import
corollari
find
studi
highlight
util
prototyp
neg
strand
virus
tool
use
screen
new
antivir
compound
util
virus
shown
minim
human
pathogen
well
character
offer
signific
advantag
newli
discov
highli
pathogen
virus
lead
compound
identif
serv
import
step
stone
discoveri
new
antivir
compound
wide
spectrum
antivir
activ
geldanamycin
synthes
drug
therapeut
program
nih
radicicol
proteosom
inhibitor
ii
obtain
calbiochem
methionin
obtain
amersham
sirna
target
polyclon
antibodi
obtain
santa
cruz
sirna
transfect
reagent
obtain
miru
biotechnolog
sirna
target
gapdh
obtain
dharmacon
antibodi
recogn
gapdh
obtain
chemicon
reagent
obtain
fischer
co
la
cross
viru
kind
gift
barri
beati
colorado
state
univers
cell
plate
reach
densiti
fb
cell
infect
vsv
describ
previous
connor
lyle
doserespons
experi
vsv
la
cross
viru
bhk
cell
infect
moi
viru
bud
cultur
media
determin
plaqu
assay
use
bhk
cell
drug
ad
coincid
infect
unless
otherwis
indic
sirna
target
human
alpha
beta
form
hela
cell
incub
sirna
use
miru
siport
transfect
reagent
hour
prior
infect
vsv
gapdh
sirna
sirna
util
use
transfect
reagent
gapdh
sirna
tranfect
obviou
cytotox
hour
posttransfect
vsv
cell
infect
vsv
hour
cell
label
methioninecontain
media
hour
radioact
media
replac
media
contain
cold
methionin
hour
time
indic
text
describ
figur
la
cross
viru
similar
procedur
follow
cell
label
minut
chase
minut
cell
lyse
ripa
buffer
protein
separ
sdspage
virion
purif
media
infect
cell
layer
top
sucros
solut
spun
minut
pellet
virion
resuspend
protein
separ
sdspage
infect
hela
cell
high
moi
low
moi
express
gfp
viru
growth
analys
carri
describ
previous
park
ward
rassa
geldanamycin
radicicol
ad
attach
viru
cell
maintain
throughout
growth
experi
gfp
express
cell
analyz
nikon
eclips
microscop
object
imag
captur
use
qimag
digit
camera
process
use
qcaptur
softwar
exposur
time
manual
set
constant
sampl
radiolabel
experi
cell
treat
geldanamycin
hr
prior
radiolabel
tran
slabel
uciml
lyse
sd
use
immunoprecipit
analysi
polyclon
antibodi
specif
np
p
l
protein
describ
previous
park
ward
rassa
refer
web
version
pubm
central
supplementari
materi
cell
infect
vsv
hour
protein
radiolabel
follow
use
one
hour
puls
one
hour
chase
protocol
upon
addit
radioact
methionin
differ
concentr
geldanamycin
ad
individu
sampl
follow
hour
chase
presenc
drug
intracellular
radiolabel
protein
determin
sdspage
electrophoresi
phosphoresc
imag
b
amount
newli
synthes
protein
incorpor
viru
determin
virion
purif
media
follow
sdspage
phosphoresc
analysi
samino
acid
incub
nonradioact
media
indic
time
lysi
analysi
immunoprecipit
antibodi
specif
np
p
l
geldanamycin
includ
radiolabel
chase
period
b
stabil
l
protein
cell
mock
infect
infect
moi
cell
treat
geldanamycin
radiolabel
minut
lyse
puls
chase
use
unlabel
methionin
hour
chase
follow
cell
lysi
sampl
immunoprecipit
use
lspecif
antibodi
c
experi
similar
b
carri
radicicol
use
instead
geldanamycin
smethionin
min
lyse
p
incub
nonradioact
media
hour
cell
lyse
incorpor
radioact
viral
protein
determin
sdspage
follow
phosphoresc
imag
